Skip to main content
. Author manuscript; available in PMC: 2012 Jan 25.
Published in final edited form as: Ann Behav Med. 2011 Jun;41(3):284–299. doi: 10.1007/s12160-010-9258-5

Table 5. Statistically significant moderators of the intervention effect at 6, 12, and 24 months post-intervention.

Moderatora 6 months 12 months 24 months



Odds ratio 95% CI Odds Ratio 95% CI Odds Ratio 95% CI
Family history of colorectal cancer
Survey-only 0.975 (0.44–2.19) 0.793 (0.35–1.77) 0.937 (0.45–1.97)
Web site 1.566 (0.75–3.29) 1.654 (0.80–3.43) 1.310 (0.63–2.70)
Tailored 2.794* (1.17–6.69) 2.576* (1.08–6.16) 2.795* (1.14–6.87)
Prior screening
Survey-only 1.227 (0.80–1.88) 1.224 (0.81–1.85) 1.380 (0.93–2.04)
Web site 2.173* (1.39–3.39) 1.787* (1.17-2.72) 2.192* (1.45–3.31)
 Tailored 2.416* (1.52–3.85) 2.239* (1.45–3.46) 2.401* (1.58–3.65)
Stage of changeb
 Survey-only 1.126 (0.96–1.32) 1.151 (0.99–1.34) 1.161 (0.84–1.61)
 Web site 1.042 (0.89–1.22) 1.080 (0.93–1.26) 1.133 (0.81–1.58)
 Tailored 1.208* (1.03–1.42) 1.217* (1.04–1.42) 1.731* (1.25–2.39)
MD recommend screening
 Survey-only 1.108 (0.72–1.69) 1.132 (0.75–1.71) 1.256 (0.85–1.86)
 Web site 0.840 (0.55–1.29) 0.786 (0.52–1.19) 0.820 (0.55–1.22)
 Tailored 1.387 (0.89–2.16) 1.546* (1.01–2.35) 1.380 (0.92–2.06)

Odds ratios and 95% CI from Mantel–Haenszel models

a

Moderators were measured on the baseline survey

b

Odds ratio for stage of change is the odds for each incremental positive increase in stage, i.e., precontemplation to contemplation, contemplation to preparation

*

p<0.05